297 related articles for article (PubMed ID: 15038666)
1. Effector peptides from glutathione-S-transferase-pi affect the activation of jun by jun-N-terminal kinase.
Adler V; Pincus MR
Ann Clin Lab Sci; 2004; 34(1):35-46. PubMed ID: 15038666
[TBL] [Abstract][Full Text] [Related]
2. Glutathione-S-Transferase as a selective inhibitor of oncogenic ras-p21-induced mitogenic signaling through blockade of activation of jun by jun-N-terminal kinase.
Villafania A; Anwar K; Amar S; Chie L; Way D; Chung DL; Adler V; Ronai Z; Brandt-Rauf PW; Yamaizumii Z; Kung HF; Pincus MR
Ann Clin Lab Sci; 2000 Jan; 30(1):57-64. PubMed ID: 10678584
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a novel JNK (c-Jun N-terminal kinase) inhibitory peptide.
Ngoei KR; Catimel B; Church N; Lio DS; Dogovski C; Perugini MA; Watt PM; Cheng HC; Ng DC; Bogoyevitch MA
Biochem J; 2011 Mar; 434(3):399-413. PubMed ID: 21162712
[TBL] [Abstract][Full Text] [Related]
4. Differences in patterns of activation of MAP kinases induced by oncogenic ras-p21 and insulin in oocytes.
Ranginwale M; Smith S; Flom J; Chie L; Kanovsky M; Chung D; Friedman FK; Robinson RC; Brandt-Rauf PW; Yamaizumi Z; Michl J; Pincus MR
Exp Cell Res; 2001 Sep; 269(1):162-9. PubMed ID: 11525649
[TBL] [Abstract][Full Text] [Related]
5. Identification of a glutathione-S-transferase effector domain for inhibition of jun kinase, by molecular dynamics.
Monaco R; Friedman FK; Hyde MJ; Chen JM; Manolatus S; Adler V; Ronai Z; Koslosky W; Pincus MR
J Protein Chem; 1999 Nov; 18(8):859-66. PubMed ID: 10839622
[TBL] [Abstract][Full Text] [Related]
6. Functional interactions of Raf and MEK with Jun-N-terminal kinase (JNK) result in a positive feedback loop on the oncogenic Ras signaling pathway.
Adler V; Qu Y; Smith SJ; Izotova L; Pestka S; Kung HF; Lin M; Friedman FK; Chie L; Chung D; Boutjdir M; Pincus MR
Biochemistry; 2005 Aug; 44(32):10784-95. PubMed ID: 16086581
[TBL] [Abstract][Full Text] [Related]
7. Two peptides derived from ras-p21 induce either phenotypic reversion or tumor cell necrosis of ras-transformed human cancer cells.
Adler V; Bowne W; Kamran I; Michl J; Friedman FK; Chin E; Zenilman M; Pincus MR
Cancer Chemother Pharmacol; 2008 Aug; 62(3):491-8. PubMed ID: 18066549
[TBL] [Abstract][Full Text] [Related]
8. Differential targeting of the stress mitogen-activated protein kinases to the c-Jun dimerization protein 2.
Katz S; Aronheim A
Biochem J; 2002 Dec; 368(Pt 3):939-45. PubMed ID: 12225289
[TBL] [Abstract][Full Text] [Related]
9. Probing biomolecular interactions of glutathione transferase M2-2 by using peptide phage display.
Edalat M; Pettersson S; Persson MA; Mannervik B
Chembiochem; 2002 Sep; 3(9):823-8. PubMed ID: 12210982
[TBL] [Abstract][Full Text] [Related]
10. IL-1 and TNF induction of matrix metalloproteinase-3 by c-Jun N-terminal kinase in trabecular meshwork.
Hosseini M; Rose AY; Song K; Bohan C; Alexander JP; Kelley MJ; Acott TS
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1469-76. PubMed ID: 16565381
[TBL] [Abstract][Full Text] [Related]
11. Glutathione S-transferase pi regulates UV-induced JNK signaling in SH-SY5Y neuroblastoma cells.
Castro-Caldas M; Milagre I; Rodrigues E; Gama MJ
Neurosci Lett; 2009 Feb; 451(3):241-5. PubMed ID: 19159663
[TBL] [Abstract][Full Text] [Related]
12. JNK phosphorylation relieves HDAC3-dependent suppression of the transcriptional activity of c-Jun.
Weiss C; Schneider S; Wagner EF; Zhang X; Seto E; Bohmann D
EMBO J; 2003 Jul; 22(14):3686-95. PubMed ID: 12853483
[TBL] [Abstract][Full Text] [Related]
13. c-Jun controls the efficiency of MAP kinase signaling by transcriptional repression of MAP kinase phosphatases.
Sprowles A; Robinson D; Wu YM; Kung HJ; Wisdom R
Exp Cell Res; 2005 Aug; 308(2):459-68. PubMed ID: 15950217
[TBL] [Abstract][Full Text] [Related]
14. Stress-induced activation of c-Jun N-terminal kinase in sensory ganglion neurons: accumulation in nuclear domains enriched in splicing factors and distribution in perichromatin fibrils.
Pena E; Berciano MT; Fernandez R; Crespo P; Lafarga M
Exp Cell Res; 2000 Apr; 256(1):179-91. PubMed ID: 10739665
[TBL] [Abstract][Full Text] [Related]
15. An effector peptide from glutathione-S-transferase-pi strongly and selectively blocks mitotic signaling by oncogenic ras-p21.
Chie L; Adler V; Friedman FK; Chung D; Pincus MR
Protein J; 2004 Apr; 23(3):235-8. PubMed ID: 15200055
[TBL] [Abstract][Full Text] [Related]
16. (--)-epigallocatechin gallate enhances prostaglandin F2alpha-induced VEGF synthesis via upregulating SAPK/JNK activation in osteoblasts.
Tokuda H; Takai S; Matsushima-Nishiwaki R; Akamatsu S; Hanai Y; Hosoi T; Harada A; Ohta T; Kozawa O
J Cell Biochem; 2007 Apr; 100(5):1146-53. PubMed ID: 17031857
[TBL] [Abstract][Full Text] [Related]
17. Activation of c-Jun NH2-terminal kinase (JNK/SAPK) in LLC-PK1 cells by cadmium.
Matsuoka M; Igisu H
Biochem Biophys Res Commun; 1998 Oct; 251(2):527-32. PubMed ID: 9792807
[TBL] [Abstract][Full Text] [Related]
18. Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphorylation of c-Jun and recruitment of the coactivator p300 by c-Jun.
Bitomsky N; Böhm M; Klempnauer KH
Oncogene; 2004 Sep; 23(45):7484-93. PubMed ID: 15334056
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase D complexes with C-Jun N-terminal kinase via activation loop phosphorylation and phosphorylates the C-Jun N-terminus.
Hurd C; Waldron RT; Rozengurt E
Oncogene; 2002 Mar; 21(14):2154-60. PubMed ID: 11948398
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
